Yousif Capital Management LLC Sells 94 Shares of Addus HomeCare Co. (NASDAQ:ADUS)

Yousif Capital Management LLC cut its holdings in Addus HomeCare Co. (NASDAQ:ADUS) by 1.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,896 shares of the company’s stock after selling 94 shares during the quarter. Yousif Capital Management LLC’s holdings in Addus HomeCare were worth $864,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently bought and sold shares of the business. Cherry Creek Investment Advisors Inc. purchased a new position in shares of Addus HomeCare during the fourth quarter valued at approximately $340,000. KBC Group NV increased its position in Addus HomeCare by 49.1% during the 4th quarter. KBC Group NV now owns 814 shares of the company’s stock valued at $102,000 after purchasing an additional 268 shares during the period. Exchange Traded Concepts LLC raised its holdings in Addus HomeCare by 2.6% in the 4th quarter. Exchange Traded Concepts LLC now owns 5,923 shares of the company’s stock worth $742,000 after purchasing an additional 150 shares in the last quarter. Janney Montgomery Scott LLC lifted its position in shares of Addus HomeCare by 0.9% in the 4th quarter. Janney Montgomery Scott LLC now owns 10,691 shares of the company’s stock worth $1,340,000 after purchasing an additional 91 shares during the period. Finally, Dakota Wealth Management boosted its stake in shares of Addus HomeCare by 24.2% during the 4th quarter. Dakota Wealth Management now owns 2,024 shares of the company’s stock valued at $254,000 after purchasing an additional 394 shares in the last quarter. Hedge funds and other institutional investors own 95.35% of the company’s stock.

Insider Transactions at Addus HomeCare

In related news, EVP Roberton James Stevenson sold 2,250 shares of the stock in a transaction on Monday, December 9th. The stock was sold at an average price of $121.00, for a total transaction of $272,250.00. Following the sale, the executive vice president now directly owns 10,217 shares of the company’s stock, valued at $1,236,257. This trade represents a 18.05 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO R Dirk Allison sold 25,000 shares of the business’s stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $124.76, for a total value of $3,119,000.00. Following the completion of the transaction, the chief executive officer now directly owns 79,397 shares of the company’s stock, valued at approximately $9,905,569.72. This trade represents a 23.95 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 39,750 shares of company stock worth $4,930,750. Corporate insiders own 4.60% of the company’s stock.

Addus HomeCare Stock Performance

Shares of ADUS stock opened at $113.22 on Friday. The company has a market capitalization of $2.05 billion, a price-to-earnings ratio of 25.91, a price-to-earnings-growth ratio of 1.55 and a beta of 1.00. Addus HomeCare Co. has a one year low of $85.94 and a one year high of $136.72. The company’s 50-day moving average is $126.04 and its 200 day moving average is $127.08.

Analyst Upgrades and Downgrades

Several analysts have commented on ADUS shares. Stephens raised their price objective on shares of Addus HomeCare from $143.00 to $145.00 and gave the stock an “overweight” rating in a report on Wednesday, November 6th. Citizens Jmp upgraded Addus HomeCare to a “strong-buy” rating in a research note on Monday, December 16th. StockNews.com raised Addus HomeCare from a “hold” rating to a “buy” rating in a research note on Friday, January 24th. Macquarie reissued an “outperform” rating and set a $139.00 price objective on shares of Addus HomeCare in a research report on Monday, November 4th. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and issued a $136.00 target price on shares of Addus HomeCare in a research report on Thursday, November 14th. One research analyst has rated the stock with a sell rating, eight have given a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Buy” and a consensus target price of $134.22.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.